Henao-Mejia et al. revealed that in comparison with WT mice, bone marrow-specific NLRP3 and ASC deficiency mice did not show any dramatic difference in MCD-induced NASH severity. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.